Nelarabine for T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma

被引：0
作者：
不详
机构：
来源：
AUSTRALIAN PRESCRIBER | 2025年 / 48卷 / 02期
关键词：
nelarabine; T-cell acute lymphoblastic leukaemia; T-cell lymphoblastic lymphoma; ADULTS;
D O I：
10.18773/austprescr.2025.016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：65 / 66
页数：2
相关论文
共 3 条
[1]   Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-Cell malignancies: A report from the children's oncology group [J].
Berg, SL ;
Blaney, SM ;
Devidas, M ;
Lampkin, TA ;
Murgo, A ;
Bernstein, M ;
Billett, A ;
Kurtzberg, J ;
Reaman, G ;
Gaynon, P ;
Whitlock, J ;
Krailo, M ;
Harris, MB .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3376-3382
[2]   Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801 [J].
DeAngelo, Daniel J. ;
Yu, Daohai ;
Johnson, Jeffrey L. ;
Coutre, Steven E. ;
Stone, Richard M. ;
Stopeck, Alison T. ;
Gockerman, Jon P. ;
Mitchell, Beverly S. ;
Appelbaum, Frederick R. ;
Larson, Richard A. .
BLOOD, 2007, 109 (12) :5136-5142
[3]   Efficacy and safety of nelarabine in patients with relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis [J].
Kathpalia, Meghavi ;
Mishra, Pinki ;
Bajpai, Ram ;
Bhurani, Dinesh ;
Agarwal, Nidhi .
ANNALS OF HEMATOLOGY, 2022, 101 (08) :1655-1666
1